πŸ‡ΊπŸ‡Έ FDA
Patent

US 7858349

Anti-cancer compounds

granted A61KA61K31/4184A61K31/427

Quick answer

US patent 7858349 (Anti-cancer compounds) held by The Regents of the University of Colorado expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/4184, A61K31/427, A61K31/445, A61K31/454